Lv4
750 积分 2024-11-04 加入
No relationship between non-IgE-mediated mechanisms (complement activation or direct activation of mast cells and basophils) during diclofenac etalhyaluronate (SI-613/ONO-5704)-induced anaphylaxis
1个月前
已完结
Appraisal of Clinical Practice Guideline: NICE Guidance on Spondyloarthritis in over 16s: diagnosis and management [NG65]
1个月前
已完结
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
2个月前
已完结
Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis
2个月前
已完结
JCS 2017 Guideline on Management of Vasculitis Syndrome ― Digest Version ―
3个月前
已完结
Management of Parkinson’s disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching
3个月前
已完结
Treating psychosis in people with Parkinson’s disease
3个月前
已完结
The US Food and Drug Administration’s Perspective on the New Antipsychotic Pimavanserin
3个月前
已关闭
Pimavanserin for the treatment of Parkinson’s disease psychosis
3个月前
已完结
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis
3个月前
已完结
皖公网安备34019202002308
